Use PARP-Inhibitors Early in Therapy for Metastatic Breast Cancer Improve Response Delay Toxic Therapy Use
Hope S. Rugo, MD, FAnnual Meeting, University of California, San Francisco shares Use PARP-Inhibitors Early in Therapy for Metastatic Breast Cancer | Improve Response & Delay Toxic Therapy Use at Annual Meeting 2018
104 Views
5 years Ago
Breast
Description
Breast Cancer
![Updates in Breast Cancer [2023] Interview - Lavasani, MD MOASC](https://oncologytubecom.cdn.ypt.me/videos/video_230824170438_v6469/video_230824170438_v6469_thumbsV2_jpg.webp?cache=1693159424_1693159424 "Updates in Breast Cancer [2023] Interview - Lavasani, MD MOASC")
Updates in Breast Cancer [2023] Interview - Lavasani, MD MOASC
![What is the best treatment for HR+ breast cancer? [2023] - Lavasani - MOASC](https://oncologytubecom.cdn.ypt.me/videos/video_230814163931_v9afd/video_230814163931_v9afd_thumbsV2_jpg.webp?cache=1692051776_1692051776 "What is the best treatment for HR+ breast cancer? [2023] - Lavasani - MOASC")
What is the best treatment for HR+ breast cancer? [2023] - Lavasani - MOASC
Hope in Sight: Breakthroughs in Metastatic Breast Cancer Care
12 Views
Elacestrant: ASCO 2023 New Analysis from the EMERALD Trial Data
68 Views
Revolutionizing Breast Cancer: Ribociclib Unveiled
23 Views
A Deep Dive into the TROPiCS-02 Breast Cancer
42 Views
Abemaciclib in Focus: A Look at monarchE Trial
39 Views
Metformin: Intratumoral Immune Infiltrates Impact Breast Cancer
63 Views
monarchE Trial Efficacy and Safety Results by Age in High-risk Early Breast Cancer
125 Views
CANKADO PRO-React eHealth Support The PreCycle Trial
26 Views
Age-specific analysis of Trastuzumab Deruxtecan in HER2+ mBC.
27 Views
Sacituzumab the Phase 3 TROPiCS-02 Trial Final OS Analysis in mBC
151 Views